Could remdesivir be a game changer for COVID patients? Experts say wait for dataOne U.S. study found recovery in patients using the drug was shortened by 31%—11 days on average versus 15 days for those just given usual care Tales from the pharmacy frontlines Doctors fret over surgery backlog after immediate COVID 19 crisis How medical experts decide which treatments should be used for COVID-19 Ontario has formed two special committees to sift through emerging research on how best to treat he new disease Ontario and B.C. data find drop in people seeking care for serious heart attacks Hypertension professional certification program for pharmacists now available Hypertension Canada program provides pharmacists with knowledge and confidence to identify and manage patients with hypertension First oral GLP-1 receptor agonist for type 2 diabetes reaches Canadian market Novo Nordisk introduces Rybelsus, an oral formulation of semaglutide ICU continues to deal with cases during COVID-19 pandemic with operating changes New guideline on treating severe and non-severe COVID-19: CMAJ Canadian technology used to assess stem cell therapy for COVID-19 First Previous 1427 1428 1429 1430 1431 Next Last
